XX-650-23 is a potent CREB Inhibitor for AML Research
Acute Myeloid Leukemia (AML) is a disease of the bone marrow, a disorder of hematopoietic stem cells due to genetic alterations in blood cell precursors resulting in overproduction of neoplastic…